ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by developing a suite of products and product candidates that include minimally ...

October 21, 2008 (Baltimore, Maryland) — Testing for high-risk human papillomavirus (HRHPV), in addition to colposcopic examination and cytology, results in a better diagnosis and fewer false ...

The American Society for Colposcopy and Cervical Pathology (ASCCP) recently released the Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors. The ...

The American Society for Colposcopy and Cervical Pathology (ASCCP) is dedicated to improving the health of women through the delivery of high-quality, evidence-based care. ASCCP is accredited by the ...

The follow-up after abnormal Pap smear and negative colposcopy is not clearly defined. This study aimed at investigating the role of hr-HPV testing in the management of abnormal Pap test and negative ...

SAN DIEGO--(BUSINESS WIRE)-- Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Dalrada Health’s abstract on the topic of Combined Pap Smear ...

VANCOUVER, BC, April 14, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, ...